Opportunities 2020 Lp Athyrium serves as Executive at BIORA THERAPEUTICS, INC., where they oversee executive responsibilities. Since joining the company, Opportunities 2020 Lp Athyrium has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Nov 9, 2022 involved purchasing 12,506,250 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Nov 9, 2022 | BIOR | $0 | Purchase | 12,506,250 | $N/A | Discretionary |
Opportunities 2020 Lp Athyrium currently holds 42,362,097 shares of BIORA THERAPEUTICS, INC. (BIOR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Opportunities 2020 Lp Athyrium has been a net neutral trader of BIOR stock. They have purchased $0 and sold $0 worth of shares.
Opportunities 2020 Lp Athyrium's most recent insider trade was on Nov 9, 2022, when they purchased 12,506,250 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted